α
AlphaSMO
/
→
Trv Gp Iv, LLC
/
Q4 2024
Trv Gp Iv, LLC — Q4 2024 13F Holdings
CIK: 0001688325
Total reported value
$266.9M
← Back to latest quarter
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
TNGX
Tango Therapeutics INC
Stock-Other
64.97%
+22.61%
—
2
PLRX
Pliant Therapeutics INC
Stock-Other
35.03%
—
—